Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
Aurinia Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: May 10, 2021
Aurinia Pharmaceuticals reported fiscal year 2020 executive compensation information on May 10, 2021.
In 2020, six executives at Aurinia Pharmaceuticals received on average a compensation package of $4.5M, a 98% increase compared to previous year.
Average pay of disclosed executives at Aurinia Pharmaceuticals
Peter Greenleaf, Chief Executive Officer, received $11M in total, which increased by 104% compared to 2019. 73% of Greenleaf's compensation, or $7.8M, was in option awards. Greenleaf also received $707K in non-equity incentive plan, $673K in salary, $1.5M in stock awards, as well as $9.5K in other compensation.
Max Colao, Chief Commercial Officer, received a compensation package of $4.8M. 76% of the compensation package, or $3.7M, was in option awards.
Joe Miller, Chief Financial Officer, earned $3.7M in 2020.
Stephen Robertson, General Counsel, received $3.6M in 2020.
Max Donley, EVP, Operations and Strategy, earned $3.3M in 2020, a 253% increase compared to previous year.
Dennis Bourgeault, Chief Financial Officer, received $704K in 2020, which increases by 21% compared to 2019.
Related executives
Peter Greenleaf
Aurinia Pharmaceuticals
Chief Executive Officer
Joe Miller
Aurinia Pharmaceuticals
Chief Financial Officer
Dennis Bourgeault
Aurinia Pharmaceuticals
Chief Financial Officer
Max Colao
Aurinia Pharmaceuticals
Chief Commercial Officer
Max Donley
Aurinia Pharmaceuticals
EVP, Operations and Strategy
Stephen Robertson
Aurinia Pharmaceuticals
General Counsel
You may also like
Source: SEC filing on May 10, 2021.